Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03386396 · ClinicalTrials.gov registry record · NA

Brain Fuel - Morning Nutrition and Cognitive Function

A NA study of Healthy and Obese, sponsored by Arkansas Children's Hospital Research Institute.

Active
Registry status
NA
Development phase
151
Enrollment target
1
Study location

NCT03386396: Active NA study of Healthy and Obese, sponsored by Arkansas Children's Hospital Research Institute.

NCT03386396 is a NA study of Healthy and Obese that is active but no longer recruiting, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 151 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03386396, a NA study of Healthy and Obese, is active but no longer recruiting, sponsored by Arkansas Children's Hospital Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
151 participants
Enrollment target
1
Study location

Study Summary

This study will help us learn more about how what a child eats can affect how their brain works.

Primary Outcome

Standardized testing

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT High protein/low carbohydrate
  • DIETARY_SUPPLEMENT High carbohydrate/low protein

Study Locations (1)

Arkansas

  • Arkansas Children's Nutrition Center - Little Rock

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2017-11-28
Est. Completion 2026-12
Phase NA

What the registry record for NCT03386396 still lists

NCT03386396 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower).

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which High protein/low carbohydrate is the first listed.

NCT03386396 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT03386396 about?

NCT03386396 is a clinical study titled "Brain Fuel - Morning Nutrition and Cognitive Function". This study will help us learn more about how what a child eats can affect how their brain works.

What is the current status of trial NCT03386396?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 151 participants. The study started on 2017-11-28. Estimated completion is 2026-12.

What conditions does trial NCT03386396 study?

This clinical trial studies the following conditions: Healthy, Obese.

What interventions are being tested in trial NCT03386396?

The interventions under investigation include: High protein/low carbohydrate (DIETARY_SUPPLEMENT), High carbohydrate/low protein (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03386396?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03386396 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03386396's enrollment target sits among peer trials

151 151st of 1090 higher than 940 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01409161 · 151 participants · Phase 2

    Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

  • NCT04245397 · 151 participants · Phase 1

    Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

  • NCT05761223 · 151 participants · Phase 1

    A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

  • NCT07195656 · 151 participants · NA

    Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03386396, the US trial registry maintained by the National Library of Medicine. NCT03386396 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.